Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Effects of iron nanoparticles on iron-corroding bacteria.

Das KR, Kerkar S, Meena Y, Mishra S.

3 Biotech. 2017 Dec;7(6):385. doi: 10.1007/s13205-017-1018-9. Epub 2017 Nov 6.

PMID:
29201585
2.

Native hypersaline sulphate reducing bacteria contributes to iron nanoparticle formation in saltpan sediment: A concern for aquaculture.

Das KR, Kowshik M, Praveen Kumar MK, Kerkar S, Shyama SK, Mishra S.

J Environ Manage. 2018 Jan 15;206:556-564. doi: 10.1016/j.jenvman.2017.10.078. Epub 2017 Nov 8.

PMID:
29127928
3.

Spatio-Temporal Monitoring and Ecological Significance of Retrievable Pelagic Heterotrophic Bacteria in Kongsfjorden, an Arctic Fjord.

Sinha RK, Krishnan KP, Kerkar S, Divya David T.

Indian J Microbiol. 2017 Mar;57(1):116-120. doi: 10.1007/s12088-016-0621-5. Epub 2016 Sep 22.

4.

Diversity of retrievable heterotrophic bacteria in Kongsfjorden, an Arctic fjord.

Sinha RK, Krishnan KP, Hatha AA, Rahiman M, Thresyamma DD, Kerkar S.

Braz J Microbiol. 2017 Jan - Mar;48(1):51-61. doi: 10.1016/j.bjm.2016.09.011. Epub 2016 Oct 15.

5.

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

Kerkar SP, Wang ZF, Lasota J, Park T, Patel K, Groh E, Rosenberg SA, Miettinen MM.

J Immunother. 2016 May;39(4):181-7. doi: 10.1097/CJI.0000000000000119.

6.

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e48-50. doi: 10.1097/QAI.0000000000000990. No abstract available.

7.

Mangrove Ecosystems: An Adopted Habitat for Pathogenic Salmonella spp.

Poharkar KV, Kerkar S, D'Costa D, Doijad S, Barbuddhe SB.

Water Environ Res. 2016 Mar;88(3):264-71. doi: 10.2175/106143016X14504669767733.

PMID:
26931537
8.

Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

Park TS, Groh EM, Patel K, Kerkar SP, Lee CC, Rosenberg SA.

J Immunother. 2016 Jan;39(1):1-7. doi: 10.1097/CJI.0000000000000101.

PMID:
26641256
9.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

10.

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6.

Draper LM, Kwong ML, Gros A, Stevanović S, Tran E, Kerkar S, Raffeld M, Rosenberg SA, Hinrichs CS.

Clin Cancer Res. 2015 Oct 1;21(19):4431-9. doi: 10.1158/1078-0432.CCR-14-3341.

11.

Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.

Viveka S, Dinesha, Shama P, Nagaraja GK, Ballav S, Kerkar S.

Eur J Med Chem. 2015 Aug 28;101:442-51. doi: 10.1016/j.ejmech.2015.07.002. Epub 2015 Jul 6.

PMID:
26186150
12.

Pulmonary mucosa-associated lymphoma in a patient with von Hippel-Lindau disease.

Straughan DM, Kerkar S, Azoury SC, Reardon ES, Schrump DS.

J Surg Case Rep. 2015 Jul 14;2015(7). pii: rjv080. doi: 10.1093/jscr/rjv080.

13.

Chemokine receptors CCR5 and CCR2 genes in HIV positive, HIV exposed seronegative and in HIV unexposed individuals: A study from Mumbai.

Chaudhari DV, Kerkar SC, Chavan V, Mehta PR, Mania-Pramanik J.

Indian J Dermatol Venereol Leprol. 2015 Sep-Oct;81(5):548. doi: 10.4103/0378-6323.158642. No abstract available.

14.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW.

Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Review.

15.

Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.

Zhang L, Morgan RA, Beane JD, Zheng Z, Dudley ME, Kassim SH, Nahvi AV, Ngo LT, Sherry RM, Phan GQ, Hughes MS, Kammula US, Feldman SA, Toomey MA, Kerkar SP, Restifo NP, Yang JC, Rosenberg SA.

Clin Cancer Res. 2015 May 15;21(10):2278-88. doi: 10.1158/1078-0432.CCR-14-2085. Epub 2015 Feb 18.

16.

Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.

Gokhale P, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, Salvi V, Mania-Pramanik J.

Indian J Med Res. 2014 Nov;140 Suppl:S36-43.

17.

Genetic variation in the promoter region of pro-inflammatory cytokine TNF-α in perinatal HIV transmission from Mumbai, India.

Ahir S, Mania-Pramanik J, Chavan V, Kerkar S, Samant-Mavani P, Nanavati R, Mehta P.

Cytokine. 2015 Mar;72(1):25-30. doi: 10.1016/j.cyto.2014.11.022. Epub 2014 Dec 24.

PMID:
25544182
18.

Halophilic and halotolerant actinomycetes from a marine saltern of Goa, India producing anti-bacterial metabolites.

Ballav S, Kerkar S, Thomas S, Augustine N.

J Biosci Bioeng. 2015 Mar;119(3):323-30. doi: 10.1016/j.jbiosc.2014.08.017. Epub 2014 Oct 22.

PMID:
25449757
19.

Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil RL, Tran E, Hanada K, Yu Z, Palmer DC, Kerkar SP, Michalek RD, Upham T, Leonardi A, Acquavella N, Wang E, Marincola FM, Gattinoni L, Muranski P, Sundrud MS, Klebanoff CA, Rosenberg SA, Fearon DT, Restifo NP.

Cancer Res. 2015 Jan 15;75(2):296-305. doi: 10.1158/0008-5472.CAN-14-2277. Epub 2014 Nov 28.

20.

Cervical cancer in Indian women reveals contrasting association among common sub-family of HLA class I alleles.

Gokhale P, Mania-Pramanik J, Sonawani A, Idicula-Thomas S, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, Salvi V.

Immunogenetics. 2014 Dec;66(12):683-91. doi: 10.1007/s00251-014-0805-2. Epub 2014 Sep 30.

PMID:
25267060
21.

A complicated case of vascular Pythium insidiosum infection treated with limb-sparing surgery.

Pan JH, Kerkar SP, Siegenthaler MP, Hughes M, Pandalai PK.

Int J Surg Case Rep. 2014;5(10):677-80. doi: 10.1016/j.ijscr.2014.05.018. Epub 2014 Aug 1.

22.

Prevalence and genetic profiles of Escherichia coli from mangroves and mangrove associated foods off Goa, India.

Poharkar KV, Kerkar S, Doijad SP, Barbuddhe SB.

Mar Pollut Bull. 2014 Aug 15;85(1):86-91. doi: 10.1016/j.marpolbul.2014.06.018. Epub 2014 Jul 4.

PMID:
25001886
23.

Timing and intensity of exposure to interferon-γ critically determines the function of monocyte-derived dendritic cells.

Kerkar SP, Chinnasamy D, Hadi N, Melenhorst J, Muranski P, Spyridonidis A, Ito S, Weber G, Yin F, Hensel N, Wang E, Marincola FM, Barrett AJ.

Immunology. 2014 Sep;143(1):96-108. doi: 10.1111/imm.12292.

24.

HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.

Gokhale PS, Sonawani A, Idicula-Thomas S, Kerkar S, Tongaonkar H, Mania-Pramanik J.

J Med Virol. 2014 Jun;86(6):968-74. doi: 10.1002/jmv.23924. Epub 2014 Mar 7.

PMID:
24610458
25.

"Model t" cells: a time-tested vehicle for gene therapy.

Kerkar SP.

Front Immunol. 2013 Sep 27;4:304. doi: 10.3389/fimmu.2013.00304. Review.

26.

Antiretroviral treatment, viral load of mothers & perinatal HIV transmission in Mumbai, India.

Ahir SP, Chavan V, Kerkar S, Samant-Mavani P, Nanavati R, Mehta PR, Mania-Pramanik J.

Indian J Med Res. 2013;138:201-8.

27.

Human leukocyte antigen B distribution in HIV discordant cohort from India.

Chaudhari DV, Chavan VR, Ahir SP, Kerkar SC, Mehta PR, Mania-Pramanik J.

Immunol Lett. 2013 Nov-Dec;156(1-2):1-6. doi: 10.1016/j.imlet.2013.09.002. Epub 2013 Sep 9.

PMID:
24029662
28.

Current Chlamydia trachomatis Infection, A Major Cause of Infertility.

Mania-Pramanik J, Kerkar S, Sonawane S, Mehta P, Salvi V.

J Reprod Infertil. 2012 Oct;13(4):204-10.

29.

Polymorphisms in major cytokine genes: a study among human immunodeficiency Virus-1 serodiscordant couples in Mumbai, India.

Chaudhari DV, Chavan VR, Kerkar SC, Mehta PR, Mania-Pramanik J.

Indian J Med Microbiol. 2013 Apr-Jun;31(2):166-72. doi: 10.4103/0255-0857.115250.

30.

CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women.

Gokhale P, Kerkar S, Tongaonkar H, Salvi V, Mania-Pramanik J.

Cancer Genet. 2013 May;206(5):154-61. doi: 10.1016/j.cancergen.2013.04.003. Epub 2013 Jul 5.

PMID:
23830732
31.

Collapse of the tumor stroma is triggered by IL-12 induction of Fas.

Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP.

Mol Ther. 2013 Jul;21(7):1369-77. doi: 10.1038/mt.2013.58. Epub 2013 Apr 9.

32.

Bacterial response to dynamic metal concentrations in the surface sediments of a solar saltern (Goa, India).

Pereira F, Kerkar S, Krishnan KP.

Environ Monit Assess. 2013 May;185(5):3625-36. doi: 10.1007/s10661-012-2814-7. Epub 2012 Aug 16.

PMID:
22892996
33.

Cellular constituents of immune escape within the tumor microenvironment.

Kerkar SP, Restifo NP.

Cancer Res. 2012 Jul 1;72(13):3125-30. doi: 10.1158/0008-5472.CAN-11-4094. Epub 2012 Jun 21. Review.

34.

The power and pitfalls of IL-12.

Kerkar SP, Restifo NP.

Blood. 2012 May 3;119(18):4096-7. doi: 10.1182/blood-2012-03-415018.

35.

Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.

Chinnasamy D, Yu Z, Kerkar SP, Zhang L, Morgan RA, Restifo NP, Rosenberg SA.

Clin Cancer Res. 2012 Mar 15;18(6):1672-83. doi: 10.1158/1078-0432.CCR-11-3050. Epub 2012 Jan 30.

36.

Arctic actinomycetes as potential inhibitors of Vibrio cholerae biofilm.

Augustine N, Wilson PA, Kerkar S, Thomas S.

Curr Microbiol. 2012 Apr;64(4):338-42. doi: 10.1007/s00284-011-0073-4. Epub 2012 Jan 10.

PMID:
22231452
37.

Th17 cells are long lived and retain a stem cell-like molecular signature.

Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, Sukumar M, Reger RN, Yu Z, Kern SJ, Roychoudhuri R, Ferreyra GA, Shen W, Durum SK, Feigenbaum L, Palmer DC, Antony PA, Chan CC, Laurence A, Danner RL, Gattinoni L, Restifo NP.

Immunity. 2011 Dec 23;35(6):972-85. doi: 10.1016/j.immuni.2011.09.019. Epub 2011 Dec 15.

38.

IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.

Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, Restifo NP.

J Clin Invest. 2011 Dec;121(12):4746-57. doi: 10.1172/JCI58814. Epub 2011 Nov 7.

39.

Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.

Klebanoff CA, Gattinoni L, Palmer DC, Muranski P, Ji Y, Hinrichs CS, Borman ZA, Kerkar SP, Scott CD, Finkelstein SE, Rosenberg SA, Restifo NP.

Clin Cancer Res. 2011 Aug 15;17(16):5343-52. doi: 10.1158/1078-0432.CCR-11-0503. Epub 2011 Jul 7.

40.

Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.

Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP.

J Immunother. 2011 May;34(4):343-52. doi: 10.1097/CJI.0b013e3182187600.

41.

Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment.

Zhang L, Kerkar SP, Yu Z, Zheng Z, Yang S, Restifo NP, Rosenberg SA, Morgan RA.

Mol Ther. 2011 Apr;19(4):751-9. doi: 10.1038/mt.2010.313. Epub 2011 Feb 1.

42.

Human Papillomavirus infection in asymptomatic population.

Kerkar SC, Latta S, Salvi V, Mania-Pramanik J.

Sex Reprod Healthc. 2011 Jan;2(1):7-11. doi: 10.1016/j.srhc.2010.11.001. Epub 2010 Nov 13.

PMID:
21147453
43.

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, Klebanoff CA, Johnson LA, Kerkar SP, Yang S, Muranski P, Palmer DC, Scott CD, Morgan RA, Robbins PF, Rosenberg SA, Restifo NP.

Blood. 2011 Jan 20;117(3):808-14. doi: 10.1182/blood-2010-05-286286. Epub 2010 Oct 22.

44.

Liver resections in metastatic gastric cancer.

Kerkar SP, Kemp CD, Avital I.

HPB (Oxford). 2010 Nov;12(9):589-96. doi: 10.1111/j.1477-2574.2010.00224.x. Review.

45.

Pulmonary resection for metastatic gastric cancer.

Kemp CD, Kitano M, Kerkar S, Ripley RT, Marquardt JU, Schrump DS, Avital I.

J Thorac Oncol. 2010 Nov;5(11):1796-805. doi: 10.1097/JTO.0b013e3181ed3514.

46.

Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.

Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP.

Cancer Res. 2010 Sep 1;70(17):6725-34. doi: 10.1158/0008-5472.CAN-10-0735. Epub 2010 Jul 20.

47.

The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone.

Kerkar SP, Kemp CD, Duffy A, Kammula US, Schrump DS, Kwong KF, Quezado M, Goldspiel BR, Venkatesan A, Berger A, Walker M, Toomey MA, Steinberg SM, Giaccone G, Rosenberg SA, Avital I.

Trials. 2009 Dec 23;10:121. doi: 10.1186/1745-6215-10-121.

48.

Bacterial vaginosis: a cause of infertility?

Mania-Pramanik J, Kerkar SC, Salvi VS.

Int J STD AIDS. 2009 Nov;20(11):778-81. doi: 10.1258/ijsa.2009.009193. Epub 2009 Oct 15.

PMID:
19833694
49.

Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma.

Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, Li Z, Bishop RJ, Wong WT, Sherry RM, Yang JC, Dudley ME, Restifo NP, Rosenberg SA, Nussenblatt RB.

Ophthalmology. 2009 May;116(5):981-989.e1. doi: 10.1016/j.ophtha.2008.12.004.

50.

Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.

Shah SU, Kerkar SP, Pazare AR.

Br J Ophthalmol. 2009 Jan;93(1):88-90. doi: 10.1136/bjo.2008.149237. Epub 2008 Oct 24.

PMID:
18952644

Supplemental Content

Loading ...
Support Center